Salera, Baby Girl .
HRN: 23-77-97 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2023
AMPICILLIN 250MG (VIAL)
10/02/2023
10/08/2023
IV
130mg
Q12hrs
PSNB Sec To Thickly MSAF
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes